公开(公告)号：US20210213038A1

公开(公告)日：2021-07-15

申请号：US17059942

申请日：2019-05-31

申请人： Glycom A/S

发明人： Louise Kristine Vigsnæs ,  Bruce McConnell ,  Kristine Rothaus Christensen

IPC分类号： A61K31/702

摘要： The invention relates to a method, compounds and compositions for the secondary prevention, treatment or dietary management of symptomatic and asymptomatic non-intestinal autoimmune diseases in a non-infant human including Sjogren's syndrome and type 1 diabetes. Said method, compounds and compositions for the secondary prevention, treatment or dietary management include human milk oligosaccharide (HMO), preferably mixtures of human milk oligosaccharides selected from the group of 2′-FL, LNnT, LNT, DFL, and 6′-SL.

公开(公告)号：US11554131B2

公开(公告)日：2023-01-17

申请号：US17059942

申请日：2019-05-31

申请人： Glycom A/S

发明人： Louise Kristine Vigsnæs ,  Bruce McConnell ,  Kristine Rothaus Christensen

IPC分类号： A61K31/702 ,  A61P37/02

摘要： The invention relates to a method, compounds and compositions for the secondary prevention, treatment or dietary management of symptomatic and asymptomatic non-intestinal autoimmune diseases in a non-infant human including Sjogren's syndrome and type 1 diabetes. Said method, compounds and compositions for the secondary prevention, treatment or dietary management include human milk oligosaccharide (HMO), preferably mixtures of human milk oligosaccharides selected from the group of 2′-FL, LNnT, LNT, DFL, and 6′-SL.